A.R.T. Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-321
Closed -$201K 212
2019
Q4
$201K Sell
321
-3,848
-92% -$1.88M 0.01% 1156
2019
Q3
$1.4M Buy
4,169
+1,850
+80% +$593K 0.07% 403
2019
Q2
$603K Buy
+2,319
New +$464K 0.03% 674
2019
Q1
Sell
-1,833
Closed -$199K 1336
2018
Q4
$199K Buy
+1,833
New +$309K 0.01% 1072

Other funds holding CDLX

A.R.T. Advisors's CDLX Position: Q1 2020 in Review

A.R.T. Advisors sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 321 shares — an estimated $201K sold.

A.R.T. Advisors first reported a position in CDLX in Q4 2018 and held it in 4 quarters. The position peaked at $1.4M in Q3 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

  • A.R.T. Advisors reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 321 Cardlytics shares in Q1 2020, an estimated $201K.
  • A.R.T. Advisors first reported a position in Cardlytics in Q4 2018 and held it in 4 quarters.
  • A.R.T. Advisors's Cardlytics position peaked at $1.4M in Q3 2019.
  • 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.